Pharmaceutical financial aspects, otherwise called pharmacoeconomics, manages flexibly and request of pharmaceutical items, just as the money saving advantage assessment of new and existing medications. Essential worries of the field incorporate extending drug openness, diminishing the cost of medications and improving the cost-viability of new medication treatments. Experts in this field have capable comprehension of medicinal services approach, human services organization and medication guidelines, combined with solid scientific aptitudes. It is a sub-order of wellbeing financial matters. A pharmacoeconomic study assesses the cost (communicated in money related terms) and impacts (communicated as far as financial worth, viability or improved personal satisfaction) of a pharmaceutical item.  The information can be published in our peer reviewed journal with impact factors and are calculated using citations not only from research articles but also review articles (which tend to receive more citations), editorials, letters, meeting abstracts, short communications, and case reports. The inclusion of these publications provides the opportunity for editors and publishers to manipulate the ratio used to calculate the impact factor and try to increase their number rapidly. Impact factor plays a major role for the particular journal. Journal with higher impact factor is considered to be more important than other ones.